I want to take a punt but can’t get over the fact that they refused to do this trial in Australia which would give it a stronger leg to sit on in front of the FDA. So there is a huge risk they have to do it again under phase 1b. But huge potential for sure
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)